Mannatech (MTEX) AI Stock Analysis

• Market Cap: $18.44M
• Dividend Yield: N/A
• Average Volume (3M): 3.71K
• Price to Earnings (P/E): 7.3
• Beta (1Y): 0.34
• Revenue Growth: -10.68%
• EPS Growth: N/A
• Country: US
• Employees: 189
• Sector: Consumer Defensive
• Sector Strength: 94
• Industry: Household & Personal Products
• EPS (TTM): 1.32
• Shares Outstanding: 1,900,930
• 10 Day Avg. Volume: 2,083
• 30 Day Avg. Volume: 3,710
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.15
• Price to Cash Flow (P/CF): 1.40
• P/FCF Ratio: 1.50
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Mannatech's overall stock score reflects significant challenges in financial performance, particularly with declining revenue and profitability pressures. Despite improvements in cash flow, operational inefficiencies remain a risk. Technically, the stock shows a bearish trend, limiting upside potential. Valuation metrics suggest the stock could be attractive for value investors, but the absence of a dividend yield limits its appeal for income-focused investors.

Mannatech Business Overview & Revenue Model

Company Description

Mannatech, Inc. (MTEX) is a global health and wellness company that operates primarily in the direct selling sector. Founded in 1993 and headquartered in Flower Mound, Texas, Mannatech specializes in dietary supplements, skincare, and weight management products. The company is best known for its pioneering work in glyconutrient technology, which involves the use of plant-based saccharides to enhance wellness. Mannatech distributes its products through a network of independent associates and members across various international markets.

How the Company Makes Money

Mannatech generates revenue primarily through the sale of its health and wellness products. The company's business model is based on direct selling, where independent associates and members promote and sell Mannatech's products to consumers. These associates earn commissions and bonuses based on their sales volume, which incentivizes network growth and product distribution. Mannatech's key revenue streams include sales of dietary supplements, skincare products, and weight management solutions. The company also benefits from its Auto Order program, which provides customers with regular shipments of their products, ensuring a consistent revenue stream. Mannatech's international presence and strategic partnerships in various regions contribute to its earnings, enabling it to tap into diverse market demands.

Mannatech Financial Statement Overview

Summary

Mannatech faces significant challenges with declining revenue and profitability pressures. The balance sheet shows moderate stability, but the declining equity ratio is a concern. Cash flow improvements provide some optimism, but the company needs to address operational inefficiencies and stabilize its revenue to enhance financial performance.

Income Statement

Mannatech's income statement shows a declining trend in revenue with negative growth rates over the recent years. The gross profit margin remains relatively robust, but profitability is a concern as indicated by negative EBIT and net profit margins in most recent periods. Despite a brief recovery in net income in 2024, the overall trajectory suggests challenges in sustaining profitability.

Balance Sheet

The balance sheet reflects moderate financial health with a manageable debt-to-equity ratio, indicating a low leverage position. However, the return on equity is inconsistent due to fluctuating net income. The equity ratio has been declining, suggesting an increasing reliance on liabilities, which could pose risks if not addressed.

Cash Flow

Cash flow analysis indicates volatility, with improvements in free cash flow in the latest year but negative trends in prior periods. The operating cash flow to net income ratio suggests operational inefficiencies, although the free cash flow to net income ratio has seen improvement recently, indicating better cash generation relative to net income.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
121.55M	117.87M	131.96M	137.21M	159.76M	151.41M
	Gross Profit
91.52M	91.46M	102.86M	104.15M	125.61M	115.90M
	EBIT
-331.00K	1.43M	-964.00K	-405.00K	9.05M	4.49M
	EBITDA
660.00K	1.43M	702.00K	1.22M	10.77M	6.48M
	Net Income Common Stockholders
-1.53M	4.99M	-2.24M	-4.49M	9.84M	6.26M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
14.71M	11.40M	7.73M	13.78M	24.18M	22.21M
	Total Assets
96.84M	36.06M	41.21M	49.13M	59.63M	65.34M
	Total Debt
1.94M	5.16M	5.73M	412.00K	339.00K	758.00K
	Net Debt
-12.77M	-6.24M	-2.00M	-13.37M	-23.85M	-21.45M
	Total Liabilities
48.08M	27.44M	30.72M	34.95M	35.21M	39.36M
	Stockholders Equity
48.76M	8.61M	10.48M	14.18M	24.41M	25.97M
Cash Flow		Free Cash Flow
951.00K	2.26M	-3.12M	-3.66M	10.12M	5.08M
	Operating Cash Flow
1.16M	2.26M	-2.37M	-2.60M	10.77M	6.03M
	Investing Cash Flow
-611.00K	-285.00K	-747.00K	-1.06M	-650.00K	-947.00K
	Financing Cash Flow
2.59M	1.96M	-1.90M	-4.33M	-9.29M	-9.92M

Mannatech Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 9.70
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Positive. The current price of 9.7 is above the 20-day moving average (MA) of 9.08, below the 50-day MA of 10.16, and above the 200-day MA of 9.25, indicating a neutral trend. The MACD of -0.11 indicates Negative momentum. The RSI at 51.40 is Neutral, neither overbought nor oversold. The STOCH value of 54.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTEX.

Mannatech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UG	71 Outperform	$38.82M	11.94	27.94%	8.28%	11.91%	25.93%
TKLF	70 Outperform	$13.05M	1.73	20.48%	―	―	―
Sector *	63 Neutral	$9.37B	14.87	4.61%	187.28%	3.96%	6.52%
TANH	56 Neutral	$2.37M	1.72	3.96%	―	6.27%	-34.07%
MTEX	51 Neutral	$18.44M	7.34	26.08%	―	-10.68%	―
GROV	43 Neutral	$42.16M	―	-159.69%	―	-21.54%	40.62%
SKIN	41 Neutral	$111.47M	―	-52.34%	―	-16.00%	69.61%

Mannatech Corporate Events

Mannatech Appoints Robert Toth as Vice Chairman

Mannatech, a leading global health and wellness company, has appointed Robert A. Toth as Vice Chairman of its Board of Directors, effective December 1, 2024. With a wealth of experience in direct selling, including a significant tenure at Avon, Toth brings extensive international expertise to Mannatech’s strategic initiatives. This move aims to leverage his insights to drive the company’s global expansion and enhance its market position.